Referências

1. Chand N., Sanyal A.J., Sepsis-induced cholestasis, Hepatology., 45, pp. 230-241, (2007)
2. Shimizu Y., Liver in systemic disease, World J Gastroenterol., 14, pp. 4111-4119, (2008)
3. Franson T.R., Hierholzer W.J., LaBrecque D.R., Frequency and characteristics of hyperbilirubinemia associated with bacteremia, Rev Infect Dis., 7, pp. 1-9, (1985)
4. Szabo G., Romics L., Frendl G., Liver in sepsis and systemic inflammatory response syndrome, Clin Liver Dis., 6, pp. 1045-1066, (2002)
5. Abdala E., Baia C.E., Mies S., Et al., Bacterial translocation during liver transplantation: a randomized trial comparing conventional with venovenous bypass vs. piggyback methods, Liver Transpl., 13, pp. 488-496, (2007)
6. Koskinas J., Gomatos I.P., Tiniakos D.G., Et al., Liver histology in ICU patients dying from sepsis: a clinicopathological study, World J Gastroenterol., 14, pp. 1389-1393, (2008)
7. Sugiyama M., Atomi Y., Pyogenic hepatic abscess with biliary communication, Am J Surg., 183, pp. 205-208, (2002)
8. Lefkowitch J.H., Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and ""cholangitis lenta., Hum Pathol., 13, pp. 19-24, (1982)
9. Cheng H.C., Chang W.L., Chen W.Y., Et al., Long-term outcome of pyogenic liver abscess: factors related with abscess recurrence, J Clin Gastroenterol., 42, pp. 1110-1115, (2008)
10. Pramoolsinsap C., Viranuvatti V., Salmonella hepatitis, J Gastroenterol Hepatol., 13, pp. 745-750, (1998)
11. Boyle E.C., Bishop J.L., Grassl G.A., Et al., Salmonella: from pathogenesis to therapeutics, J Bacteriol., 189, pp. 1489-1495, (2007)
12. Caly W.R., Farias A.Q., Carrilho F.J., Doenças hepáticas causadas por bactérias, parasitas e/ou fungos, Clínica Médica, pp. 328-343, (2009)
13. Kumar D., Srividya G., Verma S., Et al., Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis, Trans R Soc Trop Med Hyg., 102, pp. 167-171, (2008)
14. Pintado V., Martin-Rabadan P., Rivera M.L., Et al., Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study, Medicine (Baltimore)., 80, pp. 54-73, (2001)
15. Guerin P.J., Olliaro P., Nosten F., Et al., Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development, Lancet Infect Dis., 2, pp. 564-573, (2002)
16. Tuteja R., Malaria-an overview, FEBS J., 274, pp. 4670-4679, (2007)
17. Vaughan A.M., Aly A.S., Kappe S.H., Malaria parasite pre-erythrocytic stage infection: gliding and hiding, Cell Host Microbe., 4, pp. 209-218, (2008)
18. Deller J.J., Cifarelli P.S., Berque S., Et al., Malaria hepatitis, Mil Med., 132, pp. 614-620, (1967)
19. De Brito T., Barone A.A., Faria R.M., Human liver biopsy in P. falciparum and P. vivax malaria. A light and electron microscopy study, Virchows Arch A Pathol Pathol Anat., 348, pp. 220-229, (1969)
20. Rupani A.B., Amarapurkar A.D., Hepatic changes in fatal malaria: an emerging problem, Ann Trop Med Parasitol., 103, pp. 119-127, (2009)
21. Crane G.G., Hyperreactive malarious splenomegaly (tropical splenomegaly syndrome), Parasitol Today., 2, pp. 4-9, (1986)
22. Hotez P.J., Brindley P.J., Bethony J.M., Et al., Helminth infections: the great neglected tropical diseases, J Clin Invest., 118, pp. 1311-1321, (2008)
23. Coura J.R., Suarez-Mutis M., Ladeia-Andrade S., A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection-a review, Mem Inst Oswaldo Cruz., 101, pp. 229-237, (2006)
24. Shah O.J., Zargar S.A., Robbani I., Biliary ascariasis: a review, World J Surg., 30, pp. 1500-1506, (2006)
25. Bethony J., Brooker S., Albonico M., Et al., Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm, Lancet., 367, pp. 1521-1532, (2006)
26. Malik A.H., Saima B.D., Wani M.Y., Management of hepatobiliary and pancreatic ascariasis in children of an endemic area, Pediatr Surg Int., 22, pp. 164-168, (2006)
27. Khandelwal N., Shaw J., Jain M.K., Biliary parasites: diagnostic and therapeutic strategies, Curr Treat Options Gastroenterol., 11, pp. 85-95, (2008)
28. Gayotto L.C., da Silva L.C., Ascariasis, visceral larva migrans, capillariasis, strongyloidiasis and pentastomiasis, Oxford Textbook of Clinical Hepatology., pp. 730-739, (1991)
29. Lim J.H., Kim S.Y., Park C.M., Parasitic diseases of the biliary tract, AJR Am J Roentgenol., 188, pp. 1596-1603, (2007)
30. Bradley J.E., Jackson J.A., Immunity, immunoregulation and the ecology of trichuriasis and ascariasis, Parasite Immunol., 26, pp. 429-441, (2004)
31. Gayotto L.C., Muszkat R.M., Souza I.V., Hepatobiliary alterations in massive biliary ascariasis. Histopathological aspects of an autopsy case, Rev Inst Med Trop Sáo Paulo., 32, pp. 91-95, (1990)
32. Hotez P.J., Neglected infections of poverty in the United States of America, PLoS Negl Trop Dis., 2, (2008)
33. Marcos L.A., Terashima A., Dupont H.L., Et al., Strongyloides hyperinfection syndrome: an emerging global infectious disease, Trans R Soc Trop Med Hyg., 102, pp. 314-318, (2008)
34. Kwon N.H., Oh M.J., Lee S.P., Et al., The prevalence and diagnostic value of toxocariasis in unknown eosinophilia, Ann Hematol., 85, pp. 233-238, (2006)
35. Ehrhard T., Kernbaum S., Toxocara canis et toxocarose humaine, Bulletin de l'Institut Pasteur., 77, pp. 225-287, (1979)
36. Huntley C.C., Costas M.C., Lyerly A., Visceral larva migrans syndrome: clinical characteristics and immunologic studies in 51 patients, Pediatrics., 36, pp. 523-536, (1965)
37. Musso C., Castelo J.S., Tsanaclis A.M., Et al., Prevalence of Toxocara-induced liver granulomas, detected by immunohistochemistry, in a series of autopsies at a Children's Reference Hospital in Vitoria, ES, Brazil, Virchows Arch., 450, pp. 411-417, (2007)
38. Despommier D., Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects, Clin Microbiol Rev., 16, pp. 265-272, (2003)
39. Jacob C.M., Pastorino A.C., Peres B.A., Et al., Clinical and laboratorial features of visceral toxocariasis in infancy, Rev Inst Med Trop Sáo Paulo., 36, pp. 19-26, (1994)
40. Lynch N.R., Wilkes L.K., Hodgen A.N., Et al., Specificity of Toxocara ELISA in tropical populations, Parasite Immunol., 10, pp. 323-337, (1988)
41. Lynch N.R., Eddy K., Hodgen A.N., Et al., Seroprevalence of Toxocara canis infection in tropical Venezuela, Trans R Soc Trop Med Hyg., 82, pp. 275-281, (1988)
42. Galvao V.A., Capillaria hepatica: an evaluation of its pathogenic role in man, Mem Inst Oswaldo Cruz., 76, pp. 415-433, (1981)
43. Infectious Diseases: Atlas, Cases, Text, (2008)
44. Poltera A.A., Katsimbura N., Granulomatous hepatitis due to Strongyloides stercoralis, J Pathol., 113, pp. 241-246, (1974)
45. Peres L.C., Saggioro F.P., Dias L.B., Et al., Infectious diseases in paediatric pathology: experience from a developing country, Pathology., 40, pp. 161-175, (2008)
46. Assis B.C., Cunha L.M., Baptista A.P., Et al., A contribution to the diagnosis of Capillaria hepatica infection by indirect immunofluorescence test, Mem Inst Oswaldo Cruz., 99, pp. 173-177, (2004)
47. Genta R.M., Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease, Rev Infect Dis., 11, pp. 755-767, (1989)
48. Liu L.X., Weller P.F., Strongyloidiasis and other intestinal nematode infections, Infect Dis Clin North Am., 7, pp. 655-682, (1993)
49. Berk S.L., Verghese A., Alvarez S., Et al., Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee, Arch Intern Med., 147, pp. 1257-1261, (1987)
50. Segarra-Newnham M., Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection, Ann Pharmacother., 41, pp. 1992-2001, (2007)
51. Siddiqui A.A., Berk S.L., Diagnosis of Strongyloides stercoralis infection, Clin Infect Dis., 33, pp. 1040-1047, (2001)
52. Marcos L.A., Tagle M., Terashima A., Et al., Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis, Am J Trop Med Hyg., 78, pp. 222-227, (2008)
53. Voehringer D., Shinkai K., Locksley R.M., Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production, Immunity., 20, pp. 267-277, (2004)
54. Finkelman F.D., Shea-Donohue T., Morris S.C., Et al., Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites, Immunol Rev., 201, pp. 139-155, (2004)
55. Ramanathan R., Burbelo P.D., Groot S., Et al., A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection, J Infect Dis., 198, pp. 444-451, (2008)
56. Pinlaor S., Mootsikapun P., Pinlaor P., Et al., Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects, Southeast Asian J Trop Med Public Health., 36, pp. 841-845, (2005)
57. Bachur T.P., Vale J.M., Coelho I.C., Et al., Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy, Braz J Infect Dis., 12, pp. 115-122, (2008)
58. Andrade Z.A., Schistosomiasis and hepatic fibrosis regression, Acta Trop., 108, pp. 79-82, (2008)
59. Kamal S., Madwar M., Bianchi L., Et al., Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni, Liver., 20, pp. 281-289, (2000)
60. Silva L.C., Maciel P.E., Ribas J.G., Et al., Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study, Clin Infect Dis., 39, pp. 1618-1624, (2004)
61. Andrade Z.A., Schistosomal hepatopathy, Mem Inst Oswaldo Cruz., 99, pp. 51-57, (2004)
62. Parasitología Médica, (1982)
63. Bina J.C., Prata A., Regressão da hepatoesplenomegalia pelo tratamento específico da esquistossomose, Rev Soc Bras Med Trop., 16, pp. 213-218, (1983)
64. Morgenstern R., Hayes P.C., The liver in typhoid fever: always affected, not just a complication, Am J Gastroenterol., 86, pp. 1235-1239, (1991)
65. Vianna M.R., Gayotto L.C., Telma R., Et al., Intrahepatic bile duct changes in human hepatosplenic schistosomiasis mansoni, Liver., 9, pp. 100-109, (1989)
66. Mohamed-Ali Q., Doehring-Schwerdtfeger E., Abdel-Rahim I.M., Et al., Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel, Am J Trop Med Hyg., 44, pp. 444-451, (1991)
67. Richter J., The impact of chemotherapy on morbidity due to schistosomiasis, Acta Trop., 86, pp. 161-183, (2003)
68. Andrade Z.A., Morphological features of collagen degradation in advanced hepatic schistosomiasis of man, Mem Inst Oswaldo Cruz., 87, pp. 129-138, (1992)
69. Rutitzky L.I., Bazzone L., Shainheit M.G., Et al., IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17, J Immunol., 180, pp. 2486-2495, (2008)
70. Cerri G.G., Alves V.A., Magalhaes A., Hepatosplenic schistosomiasis mansoni: ultrasound manifestations, Radiology., 153, pp. 777-780, (1984)
71. Vezozzo D.C., Farias A.Q., Cerri G.G., Et al., Assessment of portal hemodynamics by Doppler ultrasound and of liver morphology in the hepatosplenic and hepatointestinal forms of schistosomiasis mansoni, Dig Dis Sci., 51, pp. 1413-1419, (2006)
72. Smith J.A., Oladiran B., Lagundoye S.B., Et al., Pentastomiasis and malignancy, Ann Trop Med Parasitol., 69, pp. 503-512, (1975)
73. Self J.T., Hopps H.C., Williams A.O., Pentastomiasis in Africans, Trop Geogr Med., 27, pp. 1-13, (1975)
74. Prathap K., Lau K.S., Bolton J.M., Pentastomiasis: a common finding at autopsy among Malaysian aborigines, Am J Trop Med Hyg., 18, pp. 20-27, (1969)
75. Khosla S.N., Singh R., Singh G.P., Et al., The spectrum of hepatic injury in enteric fever, Am J Gastroenterol., 83, pp. 413-416, (1988)
76. Hopps H.C., Keegan H.L., Price D.L., Et al., Pentastomiasis, Pathology of Protozoal and Helminthic Diseases with Clinical Correlation, pp. 970-989, (1971)
77. Machado M.A., Makdissi F.F., Canedo L.F., Et al., Unusual case of pentastomiasis mimicking liver tumor, J Gastroenterol Hepatol., 21, pp. 1218-1220, (2006)
78. Ma K.C., Qiu M.H., Rong Y.L., Pathological differentiation of suspected cases of pentastomiasis in China, Trop Med Int Health., 7, pp. 166-177, (2002)
79. Mas-Coma S., Epidemiology of fascioliasis in human endemic areas, J Helminthol., 79, pp. 207-216, (2005)
80. Marcos L.A., Terashima A., Gotuzzo E., Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis, Curr Opin Infect Dis., 21, pp. 523-530, (2008)
81. Rana S.S., Bhasin D.K., Nanda M., Et al., Parasitic infestations of the biliary tract, Curr Gastroenterol Rep., 9, pp. 156-164, (2007)
82. Lim J.H., Mairiang E., Ahn G.H., Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis, Abdom Imaging., 33, pp. 157-165, (2008)
83. O'Neill S.M., Parkinson M., Strauss W., Et al., Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase, Am J Trop Med Hyg., 58, pp. 417-423, (1998)
84. Espinoza J.R., Timoteo O., Herrera-Velit P., Fas2-ELISA in the detection of human infection by Fasciola hepatica, J Helminthol., 79, pp. 235-240, (2005)
85. Sithithaworn P., Haswell-Elkins M.R., Mairiang P., Et al., Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand, Int J Parasitol., 24, pp. 833-843, (1994)
86. Akritidis N., Tzivras M., Delladetsima I., Et al., The liver in brucellosis, Clin Gastroenterol Hepatol., 5, pp. 1109-1112, (2007)
87. Rim H.J., Clonorchiasis: an update, J Helminthol., 79, pp. 269-281, (2005)
88. Dunn M.A., Parasitic diseases, Schiff's Diseases of the Liver, pp. 1369-1371, (2007)
89. Srivatanakul P., Sriplung H., Deerasamee S., Epidemiology of liver cancer: an overview, Asian Pac J Cancer Prev., 5, pp. 118-125, (2004)
90. Lee T.Y., Lee S.S., Jung S.W., Et al., Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study, Am J Gastroenterol., 103, pp. 1716-1720, (2008)
91. Kim K.H., Kim C.D., Lee H.S., Et al., Biliary papillary hyperplasia with clonorchiasis resembling cholangiocarcinoma, Am J Gastroenterol., 94, pp. 514-517, (1999)
92. Eckert J., Deplazes P., Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern, Clin Microbiol Rev., 17, pp. 107-135, (2004)
93. Pedrosa I., Saiz A., Arrazola J., Et al., Hydatid disease: radiologic and pathologic features and complications, Radiographics., 20, pp. 795-817, (2000)
94. Czermak B.V., Akhan O., Hiemetzberger R., Et al., Echinococcosis of the liver, Abdom Imaging., 33, pp. 133-143, (2008)
95. Ozkok A., Gul E., Okumus G., Et al., Disseminated alveolar echinococcosis mimicking a metastatic malignancy, Intern Med., 47, pp. 1495-1497, (2008)
96. Saenz-Santamaria J., Moreno-Casado J., Nunez C., Role of fine-needle biopsy in the diagnosis of hydatid cyst, Diagn Cytopathol., 13, pp. 229-232, (1995)
97. Al Dahouk S., Tomaso H., Nockler K., Et al., Laboratory-based diagnosis of brucellosis-a review of the literature. Part II: serological tests for brucellosis, Clin Lab., 49, pp. 577-589, (2003)
98. Safioleas M., Safioleas C., Misiakos E.P., Why fine-needle aspiration cytology is not an adequate diagnostic method for liver hydatic cyst-reply, Arch Surg., 142, pp. 690-691, (2007)
99. Lucas S.B., Other viral and infectious diseases and HIV-related liver disease, MacSween's Pathology of the Liver, pp. 443-491, (2007)
100. Kirby B.D., Snyder K.M., Meyer R.D., Et al., Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature, Medicine (Baltimore)., 59, pp. 188-205, (1980)
101. Kirby B.D., Snyder K.M., Meyer R.D., Et al., Legionnaires' disease: clinical features of 24 cases, Ann Intern Med., 89, pp. 297-309, (1978)
102. Diederen B.M., Legionella spp. and Legionnaires' disease, J Infect., 56, pp. 1-12, (2008)
103. Sharma M., Briski L.E., Khatib R., Hepatic actinomycosis: an overview of salient features and outcome of therapy, Scand J Infect Dis., 34, pp. 386-391, (2002)
104. Guarner J., Greer P.W., Bartlett J., Et al., Congenital syphilis in a newborn: an immunopathologic study, Mod Pathol., 12, pp. 82-87, (1999)
105. Tiliakos N., Shamma'a J.M., Nasrallah S.M., Syphilitic hepatitis, Am J Gastroenterol., 73, pp. 60-61, (1980)
106. Sabbatani S., Manfredi R., Attard L., Et al., Secondary syphilis presenting with acute severe hepatic involvement in a patient with undiagnosed HIV disease, AIDS Patient Care STDS., 19, pp. 545-549, (2005)
107. Ishikawa M., Shimizu I., Uehara K., Et al., A patient with early syphilis complicated by fatty liver who showed an alleviation of hepatopathy accompanied by jaundice after receiving anti-syphilitic therapy, Intern Med., 45, pp. 953-956, (2006)
108. Palaniappan R.U., Ramanujam S., Chang Y.F., Leptospirosis: pathogenesis, immunity, and diagnosis, Curr Opin Infect Dis., 20, pp. 284-292, (2007)
109. Kobayashi Y., Clinical observation and treatment of leptospirosis, J Infect Chemother., 7, pp. 59-68, (2001)
110. de Brito T., Morais C.F., Yasuda P.H., Et al., Cardiovascular involvement in human and experimental leptospirosis: pathologic findings and immunohistochemical detection of leptospiral antigen, Ann Trop Med Parasitol., 81, pp. 207-214, (1987)
111. Carvalho C.R., Bethlem E.P., Pulmonary complications of leptospirosis, Clin Chest Med., 23, pp. 469-478, (2002)
112. Nicodemo A.C., Duarte M.I., Alves V.A., Et al., Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia, Am J Trop Med Hyg., 56, pp. 181-187, (1997)
113. De Brito T., Machado M.M., Montans S.D., Et al., Liver biopsy in human leptospirosis: a light and electron microscopy study, Virchows Arch Pathol Anat Physiol Klin Med., 342, pp. 61-69, (1967)
114. Zaki S.R., Shieh W.J., Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua, Lancet., 347, pp. 535-536, (1996)
115. Alves V.A., Vianna M.R., Yasuda P.H., Et al., Detection of leptospiral antigen in the human liver and kidney using an immunoperoxidase staining procedure, J Pathol., 151, pp. 125-131, (1987)
116. De Brito T., Menezes L.F., Lima D.M., Et al., Immunohistochemical and in situ hybridization studies of the liver and kidney in human leptospirosis, Virchows Arch., 448, pp. 576-583, (2006)
117. Athanazio D.A., Santos C.S., Santos A.C., Et al., Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans, Acta Trop., 105, pp. 95-98, (2008)
118. Walker D.H., Paddock C.D., Dumler J.S., Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections, Med Clin North Am., 92, pp. 1345-1361, (2008)
119. Adams J.S., Walker D.H., The liver in Rocky Mountain spotted fever, Am J Clin Pathol., 75, pp. 156-161, (1981)
120. Walker D.H., Ismail N., Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events, Nat Rev Microbiol., 6, pp. 375-386, (2008)
121. Chapman A.S., Bakken J.S., Folk S.M., Et al., Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals, MMWR Recomm Rep., 55, pp. 1-27, (2006)
122. Tissot-Dupont H., Raoult D., Q fever, Infect Dis Clin North Am., 22, pp. 505-514, (2008)
123. Zaidi S.A., Singer C., Gastrointestinal and hepatic manifestations of tickborne diseases in the United States, Clin Infect Dis., 34, pp. 1206-1212, (2002)
124. Tjwa M., De Hertogh G., Neuville B., Et al., Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature, Acta Clin Belg., 56, pp. 341-348, (2001)
125. Ughetto E., Gouriet F., Raoult D., Et al., Three years experience of real-time PCR for the diagnosis of Q fever, Clin Microbiol Infect, (2009)
126. Parolini I., Blanc P., Larrey D., Bacterial perihepatitis, Rev Prat., 51, pp. 2081-2085, (2001)
127. Piton S., Marie E., Parmentier J.L., Chlamydia trachomatis perihepatitis (Fitz Hugh-Curtis syndrome). Apropos of 20 cases, J Gynecol Obstet Biol Reprod (Paris)., 19, pp. 447-454, (1990)
128. Doyle D.J., Hanbidge A.E., O'Malley M.E., Imaging of hepatic infections, Clin Radiol., 61, pp. 737-748, (2006)
129. Voorhis W.C.V., Weller P.F., Protozoan infections
130. Connor D.H., Neafie R.C., Meyers W.M., Amebiasis, Pathology of Tropical and Extraordinary Diseases, pp. 308-316, (1976)
131. Pawlowski S.W., Warren C.A., Guerrant R., Diagnosis and treatment of acute or persistent diarrhea, Gastroenterology., 136, pp. 1874-1886, (2009)
132. Kubar J., Fragaki K., Recombinant DNA-derived Leishmania proteins: from the laboratory to the field, Lancet Infect Dis., 5, pp. 107-114, (2005)
133. Magill A.J., Grogl M., Gasser R.A., Et al., Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm, N Engl J Med., 328, pp. 1383-1387, (1993)
134. Stanley A.C., Engwerda C.R., Balancing immunity and pathology in visceral leishmaniasis, Immunol Cell Biol., 85, pp. 138-147, (2007)
135. Carvalho E.M., Badaro R., Reed S.G., Et al., Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis, J Clin Invest., 76, pp. 2066-2069, (1985)
136. Seixas Duarte M.I., Tuon F.F., Pagliari C., Et al., Human visceral leishmaniasis expresses Th1 pattern in situ liver lesions, J Infect., 57, pp. 332-337, (2008)
137. Scarisbrick J.J., Chiodini P.L., Watson J., Et al., Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis, Travel Med Infect Dis., 4, pp. 14-21, (2006)
138. El Hag I.A., Hashim F.A., El Toum I.A., Et al., Liver morphology and function in visceral leishmaniasis (kala-azar), J Clin Pathol., 47, pp. 547-551, (1994)
139. Andrade Z.A., Andrade S.G., Some new aspects of the kala-azar pathology. (Morphologic study of 13 autopsy cases), Rev Inst Med Trop Sáo Paulo., 8, pp. 259-266, (1966)
140. Duarte M.I., Corbett C.E., Histopathological patterns of the liver involvement in visceral leishmaniasis, Rev Inst Med Trop Sáo Paulo., 29, pp. 131-136, (1987)
141. Corbett C.E., Duarte M.I., Bustamante S.E., Regression of diffuse intralobular liver fibrosis associated with visceral leishmaniasis, Am J Trop Med Hyg., 49, pp. 616-624, (1993)
142. Guerin P.J., Olliaro P., Sundar S., Et al., Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda, Lancet Infect Dis., 2, pp. 494-501, (2002)